Miriam Smith said Tamara O'Neal, an emergency physician killed at Mercy Hospital last week, treated her nine-year-old son for fatigue, a fever, and nausea a few hours before O'Neal was fatally shot, in today's bite-sized hospital and health industry news from District of Columbia, Illinois, and Missouri.
The scientific community is reeling following a Chinese researcher's claim that he used the gene-editing technology CRISPR to create the world's first genetically modified human babies, The Hill reports.
It's becoming increasingly common for patients with rare diseases or cancer gene mutations to turn to Facebook groups for emotional support. But these groups often face privacy and financial concerns, which presents, according to Advisory Board's Tomi Ogundimu and Petra Esseling, an opportunity for providers to help patients by connecting them with their own evidence-based virtual support platforms.
Earlier this year, the Trump administration asked for recommendations on ways to ease anti-kickback laws that limits where physicians can refer Medicare beneficiaries. Providers and lobbying groups responded in force—but some legal experts say any move to ease existing laws could increase fraud and abuse.
What has Cedars-Sinai Medical Center in Los Angeles learned from treating high-profile patients such as Lucille Ball, Frank Sinatra, and—most recently—Stan Lee? Writing in JAMA Surgery, two Cedars-Sinai physicians offer their advice on how to handle media inquiries, when to consider treating a patient under an alias, and even how to ask for donations after care is provided.
A journalistic investigation by major news outlets revealed medical devices have been tied to roughly 83,000 deaths and more than 1.7 million injuries over the past decade—and now FDA says it will overhaul its system for approving most medical devices.
CMS' proposed rule seeks to eliminate barriers that prevent Medicare Part D patients from accessing lower-cost drugs by giving Part D plans more flexibility to use formulary management tools, such as prior authorizations and step therapy.
Aaron Carroll, a professor of pediatrics at Indiana University School of Medicine, in the New York Times' "The Upshot" examines the weaknesses of the peer-review process for research and explores possible improvements.